Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-03
2006-10-03
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S249000, C514S273000, C544S071000, C544S320000, C544S321000
Reexamination Certificate
active
07115601
ABSTRACT:
Compounds of the present disclosure are spirocycle-substituted pyrimidinecarboxamides. Also disclosed are pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating HIV infection and AIDS.
REFERENCES:
patent: 2004/0229909 (2004-11-01), Kiyama et al.
patent: 2005/0054645 (2005-03-01), Miyzaki et al.
patent: 2005/0204498 (2005-09-01), Saunders et al.
patent: 2004/244320 (2004-09-01), None
patent: WO2001/70829 (2001-09-01), None
patent: WO2002/070491 (2002-12-01), None
patent: WO2003/35076 (2003-05-01), None
patent: WO2003/35077 (2003-05-01), None
patent: WO2004/058756 (2004-07-01), None
patent: WO2004/058757 (2004-07-01), None
patent: WO2004/062613 (2004-07-01), None
patent: WO2004/096128 (2004-11-01), None
patent: WO2005/061490 (2005-07-01), None
patent: WO2005/061501 (2005-07-01), None
patent: WO2005/070901 (2005-08-01), None
patent: WO2005/113562 (2005-12-01), None
patent: WO2005/118589 (2005-12-01), None
patent: WO2005/118590 (2005-12-01), None
patent: WO2005/118593 (2005-12-01), None
Miles et al., Medline Abstract (The growing of HIV pandemic, Community Pract vol. 78, Issue 8, pp. 292-294) Aug. 2005.
Ulrich, Chapter 4: Crystallization, Kirk-Othmer Encyclopedia of Chemical Technology, Aug. 2002.
Marcus et al., PubMed Abstract (Intervirology, 45(4-6):260-6), 2002.
Van Heeswijk et al., PubMed Abstract (Antivir Ther 6(4):201-29) Dec. 2001.
Vippagunta et al., Cyrstalline Solids, Advanced Drug Delivery Reviews, 48, pp. 3-26, 2001.
West, Solid Solutions, Solid State Chemistry and its applications, pp. 358 & 365, 1988.
U.S. Appl. No. 11/227,526, filed Sep. 16, 2004, Krystal et al.
Neamati, N., “Patented small molecule inhibitors of HIV-1 integrase: a 10-year saga,” Expert Opinion, vol. 12, No. 5, pp. 709-724 (2002).
Godwin, C.G.P. et al, “Novel aryl diketo-containing inhibitors of HIV-1 integrase,” Drugs of the Future, vol. 27, No. 11, pp. 1101-1111 (2002).
Sunderland, C.J. et al, “6-Carboxamido-5,4-Hydroxyprimidinones: A New Class of Heterocyclic Ligands and Their Evaluation as Gadolinium Chelating Agents,” Inorg. Chemistry, vol. 40, pp. 6746-6756 (2001).
Naidu B. Narasimhulu
Sorenson Margaret E.
Bristol--Myers Squibb Company
Epperson James
Mingo Pamela A.
Rao Deepak
LandOfFree
HIV integrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HIV integrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV integrase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3695686